RMD
RESMED INC
NYSE · Healthcare · Medical - Instruments & Supplies · US
$224.99
−1.50%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$227.68
From 52W high−20.58%
Volume3.80M
Market cap$32.46B
P/E (TTM)21.6x
P/S (TTM)5.7x
Div yield1.09%
Key dataSep 18, 2026
Open
$227.68
From 52W high
−20.58%
Volume
3.80M
Market cap
$32.46B
ValuationView details →
P/E (Fwd)
18.5x
EV/EBITDA
14.8x
P/E (TTM)
21.6x
RSI (14)
53.2
MomentumView details →
1D Return
−1.50%
YTD Return
−5.55%
SummaryUpdated Jun 1, 2026
ResMed Inc. (NYSE:RMD) is a medical device company founded in 1989 and headquartered in San Diego, California. The company went public in 1995 and has evolved from a sleep apnea device manufacturer into a comprehensive digital health platform serving patients with sleep-disordered breathing and other respiratory conditions. ResMed operates globally across approximately 140 countries, developing cloud-connected medical devices and software solutions that serve both patients in their homes and healthcare providers managing out-of-hospital care.
Similar companies
Latest newsMore news →
Resmed director, chairman and CEO Michael J. Farrell sold 4,991 shares for $1,110,191 on September 8, 2026, according to a Form 4 filed with the SEC.10d agoResMed shares fell about 6% in morning trading on Friday after the company issued a weak fiscal 2027 revenue forecast.44d agoResMed reported Q2 CY2026 revenue of $1.46 billion, up 8.6% year on year, in line with analyst estimates, and adjusted EPS of $2.95, beating consensus by 2%.45d ago